Drug Shortage Report for MYLAN-RISPERIDONE ODT

Last updated on 2021-11-23 History
Report ID 8764
Drug Identification Number 02413515
Brand name MYLAN-RISPERIDONE ODT
Common or Proper name RISPERIDONE ODT
Company Name MYLAN PHARMACEUTICALS ULC
Market Status DORMANT
Active Ingredient(s) RISPERIDONE
Strength(s) 3MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 100BT
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-05-02
Estimated end date Unknown
Actual end date 2021-11-15
Shortage status Resolved
Updated date 2021-11-23
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2021-11-23 French Compare
v34 2021-11-23 English Compare
v33 2020-01-09 French Compare
v32 2020-01-09 English Compare
v31 2019-02-21 French Compare
v30 2019-02-21 English Compare
v29 2018-11-06 French Compare
v28 2018-11-06 English Compare
v27 2018-10-03 French Compare
v26 2018-10-03 English Compare
v25 2018-08-28 French Compare
v24 2018-08-28 English Compare
v23 2018-07-25 French Compare
v22 2018-07-25 English Compare
v21 2018-07-16 French Compare
v20 2018-07-16 English Compare
v19 2018-05-18 French Compare
v18 2018-05-18 English Compare
v17 2017-12-19 English Compare
v16 2017-12-18 French Compare

Showing 1 to 20 of 35